{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:19:04Z","timestamp":1788221944930,"version":"build-2803163510"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T00:00:00Z","timestamp":1786147200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T00:00:00Z","timestamp":1786147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009337","name":"Saitama Medical University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009337","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gen Thorac Cardiovasc Surg"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Despite high-level evidence support, the full Maze procedure remains underused because of complexity, prolonged arrest time, and training gaps. Therefore, we aimed to develop a simplified left atrial Maze procedure through the left atrial appendage.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>All patients with permanent atrial fibrillation treated using this technique between January 2024 and February 2025 were enrolled. The technique comprised (1) bilateral pulmonary vein isolation, (2) appendage-to-roof ablation, (3) appendage ridge ablation, (4) mitral annulus ablation, (5) endocardial bottom line ablation, (6) epicardial bottom line ablation, and (7) inferior vena cava and tricuspid line ablation. Left atrial Maze was performed through an amputated left atrial appendage. All ablation lines were created using the AtricureRF (AtriCure, Inc., Cincinnati, Ohio, United States) and CryoICE (AtriCure, Inc., Cincinnati, Ohio, United States) devices.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 17 patients, six and 11 underwent aortic valve surgery and coronary bypass grafting, respectively. Atrial fibrillation was classified as long-standing in 13 patients and persistent in four. Surgical ablation through the left atrial appendage was completed within 20\u00a0min of cardiac arrest. Overall survival and freedom from recurrent atrial fibrillation at 12-month follow-up were 94% and 86%, respectively. During follow-up, no patient required pacemaker implantation owing to new-onset complete atrioventricular block, and survivors had New York Heart Association Class I status.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This technique is safe, simple, and provides acceptable freedom from recurrent atrial fibrillation, promising optimal survival. It can be perform with shorter cardiac arrest time and fewer complications and recommended as a concomitant procedure regardless of left atriotomy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11748-026-02372-x","type":"journal-article","created":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T05:23:12Z","timestamp":1786166592000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Initial experiences of surgical left atrial maze through resected left atrial appendage"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7960-6704","authenticated-orcid":false,"given":"Takayuki","family":"Gyoten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritsushi","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahide","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shintaro","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Yoshitake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,8]]},"reference":[{"issue":"suppl 1","key":"2372_CR1","doi-asserted-by":"publisher","first-page":"i19","DOI":"10.1093\/ejcts\/ezx326","volume":"53","author":"C Ruaengsri","year":"2018","unstructured":"Ruaengsri C, Schill MR, Khiabani AJ, Schuessler RB, Melby SJ, Damiano RJ Jr. The Cox-maze IV procedure in its second decade: still the gold standard? Eur J Cardiothorac Surg. 2018;53(suppl 1):i19-25. https:\/\/doi.org\/10.1093\/ejcts\/ezx326.","journal-title":"Eur J Cardiothorac Surg"},{"key":"2372_CR2","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.athoracsur.2024.01.007","volume":"118","author":"MC Wyler von Ballmoos","year":"2023","unstructured":"Wyler von Ballmoos MC, Hui DS, Mehaffey JH, Malaisrie SC, Vardas PN, Gillinov AM, et al. The Society of Thoracic Surgeons 2023 clinical practice guidelines for the surgical treatment of atrial fibrillation. Ann Thorac Surg. 2023;118:291\u2013310. https:\/\/doi.org\/10.1016\/j.athoracsur.2024.01.007.","journal-title":"Ann Thorac Surg"},{"key":"2372_CR3","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jtcvs.2017.09.095","volume":"155","author":"FN Musharbash","year":"2018","unstructured":"Musharbash FN, Schill MR, Sinn LA, Schuessler RB, Maniar HS, Moon MR, et al. Performance of the Cox-maze IV procedure is associated with improved long-term survival in patients with atrial fibrillation undergoing cardiac surgery. J Thorac Cardiovasc Surg. 2018;155:159\u201370. https:\/\/doi.org\/10.1016\/j.jtcvs.2017.09.095.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2372_CR4","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.athoracsur.2016.10.076","volume":"103","author":"V Badhwar","year":"2017","unstructured":"Badhwar V, Rankin JS, Damiano RJ Jr, Gillinov AM, Bakaeen FG, Edgerton JR, et al. The Society of Thoracic Surgeons 2017 clinical practice guidelines for the surgical treatment of atrial fibrillation. Ann Thorac Surg. 2017;103:329\u201341. https:\/\/doi.org\/10.1016\/j.athoracsur.2016.10.076.","journal-title":"Ann Thorac Surg"},{"key":"2372_CR5","doi-asserted-by":"publisher","first-page":"euae043","DOI":"10.1093\/europace\/euae043","volume":"26","author":"S Tzeis","year":"2024","unstructured":"Tzeis S, Gerstenfeld EP, Kalman J, Saad EB, Sepehri Shamloo A, Andrade JG, et al. 2024 European Heart Rhythm Association\/Heart Rhythm Society\/Asia Pacific Heart Rhythm Society\/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation. Europace. 2024;26:euae043. https:\/\/doi.org\/10.1093\/europace\/euae043.","journal-title":"Europace"},{"key":"2372_CR6","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.hrthm.2013.10.004","volume":"11","author":"RJ Damiano Jr","year":"2014","unstructured":"Damiano RJ Jr, Badhwar V, Acker MA, Veeragandham RS, Kress DC, Robertson JO, et al. The CURE-AF trial: a prospective, multicenter trial of irrigated radiofrequency ablation for the treatment of persistent atrial fibrillation during concomitant cardiac surgery. Heart Rhythm. 2014;11:39\u201345. https:\/\/doi.org\/10.1016\/j.hrthm.2013.10.004.","journal-title":"Heart Rhythm"},{"key":"2372_CR7","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.xjon.2023.10.013","volume":"16","author":"HN Jenkins","year":"2023","unstructured":"Jenkins HN, Weiss AJ, Maigrot JA, Zhou G, Koroukian SM, Gillinov AM, et al. Trends in surgical ablation at the time of cardiac surgery among patients with atrial fibrillation. JTCVS Open. 2023;16:333\u201341. https:\/\/doi.org\/10.1016\/j.xjon.2023.10.013.","journal-title":"JTCVS Open"},{"key":"2372_CR8","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1001\/jama.2025.14679","volume":"334","author":"D Kim","year":"2025","unstructured":"Kim D, Shim J, Choi E-K, Oh IY, Kim J, Lee YS, et al. Long-term anticoagulation discontinuation after catheter ablation for atrial fibrillation: the ALONE-AF randomized clinical trial. JAMA. 2025;334:1246\u201354. https:\/\/doi.org\/10.1001\/jama.2025.14679.","journal-title":"JAMA"},{"key":"2372_CR9","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.jacc.2024.12.030","volume":"85","author":"S Rashedi","year":"2025","unstructured":"Rashedi S, Keykhaei M, Sato A, Steg PG, Piazza G, Eikelboom JW, et al. Anticoagulation and antiplatelet therapy for atrial fibrillation and stable coronary disease: meta-analysis of randomized trials. J Am Coll Cardiol. 2025;85:1189\u2013203. https:\/\/doi.org\/10.1016\/j.jacc.2024.12.030.","journal-title":"J Am Coll Cardiol"},{"key":"2372_CR10","doi-asserted-by":"publisher","first-page":"e022628","DOI":"10.1161\/JAHA.121.022628","volume":"10","author":"L Melgaard","year":"2021","unstructured":"Melgaard L, Overvad TF, Jensen M, Christensen TD, Lip GYH, Larsen TB, et al. Effectiveness and safety of NOAC versus warfarin in patients with atrial fibrillation and aortic stenosis. J Am Heart Assoc. 2021;10:e022628. https:\/\/doi.org\/10.1161\/JAHA.121.022628.","journal-title":"J Am Heart Assoc"},{"key":"2372_CR11","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1001\/jamacardio.2024.0675","volume":"9","author":"A Oraii","year":"2024","unstructured":"Oraii A, McIntyre WF, Parkash R, Kowalik K, Razeghi G, Benz AP, et al. Atrial fibrillation ablation in heart failure with reduced vs preserved ejection fraction: a systematic review and meta-analysis. JAMA Cardiol. 2024;9:545\u201355. https:\/\/doi.org\/10.1001\/jamacardio.2024.0675.","journal-title":"JAMA Cardiol"},{"key":"2372_CR12","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1161\/CIRCULATIONAHA.122.057444","volume":"146","author":"YNV Reddy","year":"2022","unstructured":"Reddy YNV, Borlaug BA, Gersh BJ. Management of atrial fibrillation across the spectrum of heart failure with preserved and reduced ejection fraction. Circulation. 2022;146:339\u201357. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.122.057444.","journal-title":"Circulation"},{"key":"2372_CR13","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1056\/NEJMoa2306037","volume":"389","author":"C Sohns","year":"2023","unstructured":"Sohns C, Fox H, Marrouche NF, Crijns HJGM, Costard-Jaeckle A, Bergau L, et al. Catheter ablation in end-stage heart failure with atrial fibrillation. N Engl J Med. 2023;389:1380\u20139. https:\/\/doi.org\/10.1056\/NEJMoa2306037.","journal-title":"N Engl J Med"},{"key":"2372_CR14","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1001\/jama.2020.16195","volume":"324","author":"M Valderr\u00e1bano","year":"2020","unstructured":"Valderr\u00e1bano M, Peterson LE, Swarup V, Schurmann PA, Makkar A, Doshi RN, et al. Effect of catheter ablation with vein of Marshall ethanol infusion vs catheter ablation alone on persistent atrial fibrillation: the Venus randomized clinical trial. JAMA. 2020;324:1620\u20138. https:\/\/doi.org\/10.1001\/jama.2020.16195.","journal-title":"JAMA"},{"key":"2372_CR15","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.1111\/jce.70114","volume":"36","author":"BC Hsia","year":"2025","unstructured":"Hsia BC, Zhang P, Junarta J, Garber L, Yang F, Spinelli M, et al. Vein of Marshall ethanol ablation as a strategy for recurrent persistent atrial fibrillation. J Cardiovasc Electrophysiol. 2025;36:3163\u201372. https:\/\/doi.org\/10.1111\/jce.70114.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2372_CR16","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.hrthm.2021.03.041","volume":"18","author":"N Derval","year":"2021","unstructured":"Derval N, Pambrun T, Ha\u00efssaguerre M. Strategy after vein of Marshall ethanol infusion added to catheter ablation of persistent atrial fibrillation: please follow the line. Heart Rhythm. 2021;18:1055\u20136. https:\/\/doi.org\/10.1016\/j.hrthm.2021.03.041.","journal-title":"Heart Rhythm"},{"key":"2372_CR17","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1111\/jce.16752","volume":"36","author":"S Kawai","year":"2025","unstructured":"Kawai S, Sakamoto K, Tanaka A, Inoue S, Nagaoka K, Matsuura H, et al. Clinical characteristics and ablation outcomes of recurrent atrial tachyarrhythmia after maze operation-A multicenter study in Fukuoka. J Cardiovasc Electrophysiol. 2025;36:1886\u201394. https:\/\/doi.org\/10.1111\/jce.16752.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2372_CR18","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1016\/j.hrthm.2021.06.1202","volume":"18","author":"T Pambrun","year":"2021","unstructured":"Pambrun T, Derval N, Duchateau J, Denis A, Chauvel R, Tixier R, et al. Epicardial course of the musculature related to the great cardiac vein: anatomical considerations and clinical implications for mitral isthmus block after vein of Marshall ethanol infusion. Heart Rhythm. 2021;18:1951\u20138. https:\/\/doi.org\/10.1016\/j.hrthm.2021.06.1202.","journal-title":"Heart Rhythm"},{"key":"2372_CR19","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/j.athoracsur.2020.11.027","volume":"112","author":"E Aranda-Michel","year":"2021","unstructured":"Aranda-Michel E, Serna-Gallegos D, Kilic A, Gleason T, Navid F, Zalewski A, et al. The impact of the Cox-maze technique on freedom from atrial fibrillation. Ann Thorac Surg. 2021;112:1417\u201323. https:\/\/doi.org\/10.1016\/j.athoracsur.2020.11.027.","journal-title":"Ann Thorac Surg"},{"key":"2372_CR20","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/j.athoracsur.2021.03.056","volume":"113","author":"E Aranda-Michel","year":"2022","unstructured":"Aranda-Michel E, Sultan I. Surgery for atrial fibrillation: different paths, same destination. Ann Thorac Surg. 2022;113:1050\u20131. https:\/\/doi.org\/10.1016\/j.athoracsur.2021.03.056.","journal-title":"Ann Thorac Surg"},{"key":"2372_CR21","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.iccl.2022.01.001","volume":"11","author":"RJ Lee","year":"2022","unstructured":"Lee RJ, Hanke T. The strengths and weaknesses of left atrial appendage ligation or exclusion (LARIAT, AtriaClip, surgical suture). Interv Cardiol Clin. 2022;11:205\u201317. https:\/\/doi.org\/10.1016\/j.iccl.2022.01.001.","journal-title":"Interv Cardiol Clin"},{"key":"2372_CR22","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1111\/jce.15181","volume":"32","author":"F Rosati","year":"2021","unstructured":"Rosati F, de Maat GE, Valente MAE, Mariani MA, Benussi S. Surgical clip closure of the left atrial appendage. J Cardiovasc Electrophysiol. 2021;32:2865\u201372. https:\/\/doi.org\/10.1111\/jce.15181.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2372_CR23","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.jjcc.2025.01.014","volume":"85","author":"M Shinohara","year":"2025","unstructured":"Shinohara M, Saji M, Koike H, Ohara H, Enomoto Y, Nakanishi R, et al. Current evidence and indications for left atrial appendage closure. J Cardiol. 2025;85:268\u201374. https:\/\/doi.org\/10.1016\/j.jjcc.2025.01.014.","journal-title":"J Cardiol"},{"key":"2372_CR24","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1093\/icvts\/ivs136","volume":"15","author":"CT Starck","year":"2012","unstructured":"Starck CT, Steffel J, Emmert MY, Plass A, Mahapatra S, Falk V, et al. Epicardial left atrial appendage clip occlusion also provides the electrical isolation of the left atrial appendage. Interact Cardiovasc Thorac Surg. 2012;15:416\u20138. https:\/\/doi.org\/10.1093\/icvts\/ivs136.","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"2372_CR25","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1161\/CIRCULATIONAHA.109.928903","volume":"122","author":"L Di Biase","year":"2010","unstructured":"Di Biase L, Burkhardt JD, Mohanty P, Sanchez J, Mohanty S, Horton R, et al. Left atrial appendage: an underrecognized trigger site of atrial fibrillation. Circulation. 2010;122:109\u201318. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.928903.","journal-title":"Circulation"},{"key":"2372_CR26","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.athoracsur.2020.06.015","volume":"111","author":"A Churyla","year":"2021","unstructured":"Churyla A, Andrei AC, Kruse J, Cox JL, Kislitsina ON, Liu M, et al. Safety of atrial fibrillation ablation with isolated surgical aortic valve replacement. Ann Thorac Surg. 2021;111:809\u201317. https:\/\/doi.org\/10.1016\/j.athoracsur.2020.06.015.","journal-title":"Ann Thorac Surg"}],"container-title":["General Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11748-026-02372-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11748-026-02372-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11748-026-02372-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:03:18Z","timestamp":1788220998000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11748-026-02372-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,8]]},"references-count":26,"alternative-id":["2372"],"URL":"https:\/\/doi.org\/10.1007\/s11748-026-02372-x","relation":{},"ISSN":["1863-6705","1863-6713"],"issn-type":[{"value":"1863-6705","type":"print"},{"value":"1863-6713","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,8]]},"assertion":[{"value":"23 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"TG, RK, HM, TA, SN, and AY declare no conflicts of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the institutional ethics committee of Saitama Medical University International Medical Center (reference no. 2025-127).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all patients.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}